PR91753

HAIFA, Israel and MIAMI, Fla., Sept. 20, 2021 /PRNewswire=KYODO JBN/ --

Insightec(R) [ http://www.insightec.com/ ] , a global healthcare company

focused on transforming patient care, announced its incisionless neurosurgery

platform, the Exablate(R) 4000, has received market approval by the Central

Drugs Standard Control Organization (CDSCO), part of the Ministry of Health and

Family Welfare of India.

The Exablate 4000 (Exablate Neuro) platform uses MR-guided focused ultrasound

to precisely ablate a small target deep within the brain without incisions. The

approval will enable treatment of patients in India living with Essential

Tremor, Tremor-dominant Parkinson's Disease and Neuropathic Pain.

"This approval adds to the growing recognition of the value of Focused

Ultrasound for global healthcare systems," commented Maurice R. Ferre MD,

Insightec CEO and Chairman of the Board of Directors. "More importantly,

expanded access to our technology is helping to transform the lives of people

living with debilitating medical conditions."

Essential Tremor is a neurological condition that causes uncontrollable shaking

in an estimated 41 million people worldwide. More than 80 medical centers

around the globe are treating Essential Tremor patients with the Exablate Neuro

on a regular basis. Performed in a single session in an MRI suite, many

patients experience immediate tremor relief in the treated hand with minimal

side effects.

"This technology offers appropriate patients immediate tremor control with a

less invasive procedure that requires no incisions or anesthesia with minimal

complications," said Prof. Paresh Doshi, Director of Neurosurgery at Jaslok

Hospital and Research Centre and Group Advisor Functional Neurosurgery, Apollo

Group of Hospitals, President of The Neuromodulation Society of India and Past

President of the Indian Society for Stereotactic and Functional Neurosurgery.

"Global clinical studies have demonstrated the procedure as approved is safe

and helps patients to regain daily function."

About Insightec

Insightec is a global healthcare company creating the next generation of

patient care by realizing the therapeutic power of acoustic energy. The

company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to

provide tremor treatment to patients with medication-refractory Essential

Tremor and Tremor-dominant Parkinson's Disease. Research for future

applications in the neuroscience space is underway in partnership with leading

academic and medical institutions. Insightec is headquartered in Haifa, Israel,

and Miami, with offices in Dallas, Shanghai and Tokyo.

Follow us on  Facebook [ https://www.facebook.com/INSIGHTEC.MRgFUS/ ], LinkedIn

[ https://www.linkedin.com/company/insightec/ ] and Twitter [

https://twitter.com/INSIGHTEC ] or visit www.insightec.com for more information.

Forward-looking Statements

This document contains forward-looking statements regarding, among other

things, plans, expectations, and future events.  In some cases, forward-looking

statements can be identified by the following words: "may," "can," "will,"

"could," "would," "should," "expect," "intend," "plan," "anticipate,"

"believe," "estimate," "predict," "project," "potential," "promise,"

"continue," "ongoing," or the negative of these terms. Forward-looking

statements involve known and unknown risks, uncertainties and other important

factors that could cause actual results to differ materially from what is

expressed or implied by the statements. Any forward-looking statement is based

on information available to Insightec as of the date of the statement. All

written or oral forward-looking statements attributable to Insightec are

qualified by this caution. Insightec does not undertake any obligation to

update or revise any forward-looking statement to reflect any change in

circumstances or in Insightec's expectations.

"Exablate," and "Exablate Neuro," as well as the "INSIGHTEC" logo, whether

standing alone or in connection with the word " Insightec", are protected

trademarks of Insightec.

Insightec Media Contact

G&S Business Communications for Insightec

Elizabeth Mannheimer

+1 917.595.3034  

emannheimer@gscommunications.com

Logo - https://mma.prnewswire.com/media/1120780/Insightec_Logo.jpg  

Source:  Insightec